Lanthanum enhances in vitro osteoblast differentiation via pertussis toxin-sensitive Gi protein and ERK signaling pathway

Journal of Cellular Biochemistry

Volumn 105, Issue 5, 2008, Pages 1307-1315

  Wang, Xi ^a   Yuan, Lan ^b   Huang, Jian ^a   Zhang, Tian Lan ^a   Wang, Kui ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Differentiation; ERK pathway; Gi protein; LA3+; Osteoblast

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; COLLAGEN TYPE 1; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LANTHANUM; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCALCIN; OSTEOPONTIN; PERTUSSIS TOXIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; LANTHANUM; MAP KINASE SIGNALING SYSTEM; OSTEOBLASTS; PERTUSSIS TOXIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 57149094853     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21932     Document Type: Article

References (42)

1. 3+ binding site of metabotropic glutamate receptor 1alpha. FEBS Lett 545:233-238.
2. Behets GJ, Dams G, Vercauteren SR, Damment SJ, Bouillon R, De-Broe ME, D'Haese PC. 2004a. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? J Am Soc Nephrol 15:2219-2228.
3. Behets GJ, Verberckmoes SC, D'Haese PC, De-Broe ME. 2004b. Lanthanum carbonate: A new phosphate binder. Curr Opin Nephrol Hypertens 13:403-409.
4. Berns JS, Kobrin S. 2006. Boning up on lanthanum. Semin Dial 19:87-89.
5. Block BM, Stacey WC, Jones SW. 1998. Surface charge and lanthanum block of calcium current in bullfrog sympathetic neurons. Biophys J 74:2278-2284.
6. Bodine PVN, Trailsmith M, Komm BS. 1996. Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res 11:806-819.
7. Caravan P. 2006. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 35:512-523.
8. Caverzasio J, Palmer G, Suzuki A, Bonjour JP. 1997. Mechanism of the mitogenic effect of fluoride on osteoblast-like cells: Evidences for a G protein-dependent tyrosine phosphorylation process. J Bone Miner Res 12:1975-1983.
9. Caverzasio J, Palmer G, Suzuki A, Bonjour JP. 2000. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (ERK) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells. J Bone Miner Res 15:1697-1706.
10. Chen YJ, Wang CJ, Yang KD, Chang PR, Huang HC, Huang YT, Sun YC, Wang FS. 2003. Pertussis toxin-sensitive Gαi protein and ERK-dependent pathways mediate ultrasound promotion of osteogenic transcription in human osteoblasts. FEBS Lett 554:154-158.
11. Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, Riccardi D. 2004. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 101:5140-5145.
12. Harada S, Rodan GA. 2003. Control of osteoblast function and regulation of bone mass. Nature 423:349-355.
13. Hardie MJ, Raston CL, Salinas A. 2001. A 3, 12-connected vertice sharing a damantoid hydrogen bonde network featuring tetrameric clusters of cyclotriveratrylene. Chem Commun 21:1850-1851.
14. Huang J, Zhang TL, Xu SJ, Li RC, Wang K, Zhang J, Xie YN. 2006. Effects of lanthanum on composition, crystal size, and lattice structure of femur bone mineral of Wistar rats. Calcif Tissue Int 78:241-247.
15. Jalilehvand F, Spangberg D, Lindqvist-Reis P, Hermansson K, Persson I, Sandstrom M. 2001. Hydration of the calcium ion. An EXAFS, large-angle x-ray scattering, and molecular dynamics simulation study. J Am Chem Soc 123:431-441.
16. Jarup L. 2002. Cadmium overload and toxicity. Nephrol Dial Transplant 17:35-39.
17. Komori T. 2003. Requisite roles of Runx2 and Cbfb in skeletal development. J Bone Miner Metab 21:193-197.
18. Lacour B, Auchere D, Ruellan N, de Serre Patey NM, Drueke TB. 2005. Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int 67:1062-1069.
19. Lau KH, Baylink DJ. 1998. Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res 13:1660-1667.
20. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
22. Lynch MP, Stein JL, Stein GS, Lian JB. 1995. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 216:35-45.
23. Magda D, Miller RA. 2006. Motexafin gadolinium: A novel redox active drug for cancer therapy. Semin Cancer Biol 16:466-476.
24. Miledi R. 1971. Lanthanum ions abolish the "calcium response" of nerve terminals. Nature 229:410-411.
25. Nakashima K, de Crombrugghe B. 2003. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19:458-466.
26. Naor Z, Benard O, Seger R. 2000. Activation of MAPK cascades by G protein-coupled receptors: The case of gonadotrophin-releasing hormone receptor. Trends Endocrinol Metab 11:91-99.
27. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF. 1998. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95:4040-4045.
28. Peng J, Bencsik M, Louie A, Lu W, Millard S, Nguyen P, Burghardt A, Majumdar S, Wronski TJ, Halloran B, Conklin BR, Nissenson RA. 2008. Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia. Endocrinology 149:1329-1337.
29. Pi M, Quarles LD. 2004. A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. J Bone Miner Res 19:862-869.
30. Pi M, Garner SC, Flannery P, Spurney RF, Quarles LD. 2000. Sensing of extracellular cations in CASR-deficient osteoblasts. Evidence for a novel cation-sensing mechanism. J Biol Chem 275:3256-3263.
31. Pi M, Faber P, Ekema G, Jackson PD, Ting A, Wang N, Fontilla-Poole M, Mays RW, Brunden KR, Harrington JJ, Quarles LD. 2005. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 280:40201-40209.
32. Quarles LD, Hartle JE II, Middleton JP, Zhang J, Arthur JM, Raymond JR. 1994. Aluminum-induced DNA synthesis in osteoblasts: Mediation by a G-protein coupled cation sensing mechanism. J Cell Biochem 56:106-117.
33. Robey P, Termine JD. 1985. Human bone cells in vitro. Calcif Tissue Int 37:453-460.
34. 2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells. Cell Signal 20:613-624.
35. Spurney RF, Pi M, Flannery P, Quarles LD. 1999. Aluminum is a weak agonist for the calcium-sensing receptor. Kidney Int 55:1750-1758.
36. Strack S. 2002. Overexpression of the protein phosphatase 2A regulatory subunit Bgamma promotes neuronal differentiation by activating the MAP kinase (MAPK) cascade. J Biol Chem 277:41525-41532.
37. Susa M, Standke JR, Jeschke M, Rohner D. 1997. Fluoroaluminate induces pertussis toxin-sensitive protein phosphorylation: Differences in MC3T3-E1 osteoblastic and NIH3T3 fibroblastic cells. Biochem Biophys Res Commun 235:680-684.
38. Suzuki A, Palmer G, Bonjour JP, Caverzasio J. 1998. Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone 23:197-203.
39. Thompson KO, Orvig C. 2006. Lanthanide compounds for therapeutic and diagnostic applications. Chem Soc Rev 35:499.
40. Wada T, McKee MD, Steitz S, Giachelli CM. 1999. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin. Circ Res 84:166-178.
41. Wang K. 1997. The analogy in chemical and biological behavior between non-special ions compared with essential ions. S Afr J Chem 50:232-238.
42. 3+-induced extracellular signal-regulated kinase (ERK) signaling via a metal-sensing mechanism linking proliferation and apoptosis in NIH 3T3 cells. Biochemistry 45:11217-11225.